Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy
NCT ID: NCT03382743
Last Updated: 2018-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
200 participants
INTERVENTIONAL
2017-12-20
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in Women With Primary Infertility
NCT06769204
Targeted Lidocaine Infusion for Pain Reduction in Office Hysteroscopy
NCT07318285
Comparative Efficacy of Lidocaine Spray Versus Vaginal Dinoprostone in IUD Insertion
NCT04339361
Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy
NCT04518202
Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in IUD Insertion
NCT04339049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (Lidocaine group)
5 sprays of endocervical Lidocaine 10% spray ( AstraZeneca, bedforshire) are used 3 minutes before office hysteroscopy
Endocervical Lidocaine spray
5 sprays of endocervical Lidocaine spray (10%) is used 3 minutes before office hysteroscopy
Group B (control group)
office hysteroscopy is done without analgesia
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endocervical Lidocaine spray
5 sprays of endocervical Lidocaine spray (10%) is used 3 minutes before office hysteroscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
sarah mohamed hassan
principal investigator ,lecturer of obstetrics and gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr El Ainiy Hospital
Cairo, , Egypt
Kasr Alaini hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
171217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.